Drugs / Oral mucosal immunoprophylaxis (OMIP)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00346398 | May 2006 → Jul 2011 | allergic disease, asthma | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oral mucosal immunoprophylaxis (OMIP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00346398 ↗ |
| Route | Oral | “the experimental arm participants will receive OMIP therapy (a mixture of house dust mite, cat, and timothy grass allergens) as daily oral drops under the tongue for 1 year” NCT00346398 ↗ |